Cdk4/6-Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-0685
Full Text
Open PDFAbstract
Available in full text
Date
September 21, 2018
Authors
Publisher
American Association for Cancer Research (AACR)